pr-inside.com
Back
Print

Dynavax to Report Third Quarter 2009 Financial Results after Market Closes on October 22, 2009



2009-10-21 22:48:02 -

Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to report third quarter 2009 financial results after the market closes on Thursday, October 22, 2009.

The Company also plans to host a webcast of a conference call on Thursday, October 22, 2009 at 4:30 pm EDT (1:30 pm PDT). To access the live audio webcast and the subsequent archived audio

recording of the presentation, please log onto Dynavax’s website at investors.dynavax.com/newsevents.cfm : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finv .. .



About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The Company's lead product candidate is HEPLISAVTM, a Phase 3 investigational adult hepatitis B vaccine designed to provide more rapid and increased protection with fewer doses than current licensed vaccines. For more information visit www.dynavax.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .



Dynavax Technologies CorporationAmy Figueroa, 510-665-7211Investor
Relations and Corporate CommunicationsEmail: afigueroa@dynavax.com : mailto:afigueroa@dynavax.com

Author:
Hossam Abdel-Kader
e-mail
Web: http://www.pr-inside.com/
Telefon: +43 1 9582319




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.